CoChat

Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency

Mazziotti, G, Porcelli, T, Bianchi, A, Cimino, V, Patelli, I, Mejia, C, Fusco, A, Giampietro, A, De Marinis, L, Giustina, A · 2010 · European Journal of Endocrinology

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Objective: GH deficiency (GHD) and glucocorticoid excess are associated with increased risk of fragility fractures. We aimed to evaluate whether the prevalence of vertebral fractures may be influenced by glucocorticoid over-replacement in hypopituitary males with GHD. Design: Cross-sectional study. Methods: Fifty-one adult hypopituitary patients (all males; mean age 55 years, range: 23–81) with severe adult-onset GHD (replaced in 21 patients and untreated in 30 patients) and glucocorticoid deficiency on replacement treatment were studied for vertebral fractures using a radiological and morphometric approach. Results: Vertebral fractures were observed in 31 patients (60.8%) in correlation with untreated GHD, urinary cortisol values, and cortisone doses. Patients were stratified according to treatment of GHD, and current and cumulative cortisone doses. In untreated GHD, vertebral fractures occurred more frequently in patients who had received higher (greater than median) cumulative and current doses of cortisone compared with patients who had received lower (less than median) drug doses (95.2 vs 50.0%, P=0.009 and 90.5 vs 55.6%, P=0.04 respectively). In untreated GHD, fractured patients had significantly higher urinary cortisol values compared with patients without vertebral fractures (84 μg/24 h, range: 24–135 vs 49 μg/24 h, range: 30–96; P=0.04). In treated GHD patients, by contrast, the prevalence of vertebral fractures was not influenced by cumulative and current cortisone doses and urinary cortisol values. Conclusions: Glucocorticoid over-replacement may increase the prevalence of vertebral fractures in patients with untreated GHD. However, treatment of GHD seems to protect the skeleton from the deleterious effects of glucocorticoid overtreatment in hypopituitary patients.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje-10-0125

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 46 references

Research works printed but not linked: 1

  1. Giustina, 1995, Journal of Clinical Endocrinology & Metabolism, 80, 122, 10.1210/jc.80.1.122 · DOI

Cited by

See all 68

Metadata

Authors
Mazziotti, G., Porcelli, T., Bianchi, A., Cimino, V, Patelli, I., Mejia, C., Fusco, A., Giampietro, A., De Marinis, L., & Giustina, A.
Affiliations
  • University of Brescia (IT)
  • Università Cattolica del Sacro Cuore (IT)
Corresponding author
Giustina, A
Venue
European Journal of Endocrinology
Published
2010-07
Volume
163
Issue
1
Pages
15-20
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2109123900
Cited by
68
References
45
Citations by year
2026: 2 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 6 · 2020: 3 · 2019: 1 · 2018: 7 · 2017: 6 · 2016: 8 · 2015: 6 · 2014: 8 · 2013: 6 · 2012: 2
FWCI
2.41
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
glucocorticoid replacement therapy, vertebral fractures, hypopituitarism, growth hormone deficiency, urinary cortisol, fragility fractures, bone mineral density, adult-onset growth hormone deficiency
MeSH terms
Adult, Aged, Aged, 80 and over, Glucocorticoids, Humans, Hydrocortisone, Male, Middle Aged, Testosterone, Logistic Models, Spinal Fractures, Human Growth Hormone, Hormone Replacement Therapy, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency. https://app.cochat.ai/papers/10.1530/eje-10-0125
The paper
Mazziotti, G., Porcelli, T., Bianchi, A., Cimino, V, Patelli, I., Mejia, C., Fusco, A., Giampietro, A., De Marinis, L., & Giustina, A. (2010). Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency. European Journal of Endocrinology. https://doi.org/10.1530/eje-10-0125

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.